Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-01, Stock:LLY, The news for the past five days is as follows:
2019-02-22: NEWS1: Merck to Buy Immunotherapy Developer Immune Design for $300M.NEWS2: U.S. Senators launch bipartisan probe into rising insulin prices.NEWS3: ELAN or ZTS: Who Is Expected to Report Faster EPS Growth?.NEWS4: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS5: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS6: Is Eli Lilly and Company’s (NYSE:LLY) Balance Sheet Strong Enough To Weather A Storm?.NEWS7: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS8: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS9: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS10: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS11: New Research Coverage Highlights FedEx, Honeywell International, Nielsen Holdings Plc, Changyou, J.B. Hunt Transport Services, and Eli Lilly — Consolidated Revenues, Company Growth, and Expectations for 2019.NEWS12: What Pharma Investors Need to Know About Pfizer's Latest Disaster.NEWS13: What Pharma Investors Need to Know About Pfizer's Latest Disaster.NEWS14: What Pharma Investors Need to Know About Pfizer&apos;s Latest Disaster.
2019-02-25: NEWS1: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS2: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS3: Better Buy: Eli Lilly vs. Johnson & Johnson.NEWS4: Better Buy: Eli Lilly vs. Johnson & Johnson.NEWS5: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS6: Better Buy: Eli Lilly vs. Johnson & Johnson.
2019-02-26: NEWS1: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS2: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS3: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS4: 5 Companies Hit 52-Week Highs.NEWS5: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS6: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS7: Better Buy: GlaxoSmithKline vs. Eli Lilly.
2019-02-27: NEWS1: Notable Wednesday Option Activity: FDS, LLY, MGPI.NEWS2: Notable Wednesday Option Activity: FDS, LLY, MGPI.NEWS3: Roche Holdings to Acquire Spark Therapeutics.
2019-02-28: NEWS1: Cramer: I'm kicking myself for not recommending these stocks.NEWS2: Cramer: I'm kicking myself for not recommending these stocks.NEWS3: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS4: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS5: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS6: What’s Expected for AstraZeneca’s or Eli Lilly’s EPS Growth.NEWS7: Woburn's Abpro strengthens Chinese ties with immuno-oncology deal.NEWS8: Drug Price Debate: is Legislation Necessary?.NEWS9: Will AstraZeneca or Eli Lilly Report More Revenue Growth?.NEWS10: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.NEWS11: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.NEWS12: Analysts’ Recommendations for AstraZeneca and Eli Lilly.NEWS13: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.

Answer: Rise